Access Management , Governance & Risk Management , Identity & Access Management

IAM's Role in the Pharmaceutical Sector

Sandy Dalal of Allergan on Achieving Security Stability
Sandy Dalal, director of IAM, Allergan

Mergers and acquisitions, along with cloud adoption, are rapidly changing the pharmaceutical industry. Sandy Dalal of Allergan talks about how Okta identity and access management brings security stability and supports a zero trust framework.

See Also: NHS Ransomware Attack: Healthcare Industry Infrastructures Are Critical

In an interview at Information Security Media Group’s recent Healthcare Security Summit in New York, Dalal discusses:

  • How the cloud is changing the pharmaceutical market;
  • Why zero trust is essential in an era of mergers and acquisitions;
  • How identity and access management can make the onboarding process more efficient and secure.

Dalal is director of identity and access management services at the pharmaceutical company Allergan. He is accountable for global service delivery and lifecycle management of identity, account management and end-user access management processes. Prior to joining Allergan, Dalal was a senior manager in PwC's advisory cybersecurity and privacy practice.

About the Author

Scott Ferguson

Scott Ferguson

Former Managing Editor, GovInfoSecurity, ISMG

Ferguson was the managing editor for the media website at Information Security Media Group. Before joining ISMG, he was editor-in-chief at eWEEK and director of audience development for InformationWeek. He's also written and edited for Light Reading, Security Now, Enterprise Cloud News, TU-Automotive, Dice Insights and

Around the Network

Our website uses cookies. Cookies enable us to provide the best experience possible and help us understand how visitors use our website. By browsing, you agree to our use of cookies.